These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 13161948)

  • 21. Nutritional supplementation with amino acids in cardiovascular and metabolic diseases: hypermetabolic syndrome as a therapeutic target. Introduction.
    Gheorghiade M; Filippatos GS; Fonarow GC; Anker SD
    Am J Cardiol; 2008 Jun; 101(11A):1E-2E. PubMed ID: 18514617
    [No Abstract]   [Full Text] [Related]  

  • 22. Background to the therapeutic potential of essential amino acid analogues.
    Richards P
    Z Ernahrungswiss Suppl; 1976 Jun 17-19; (19):1-4. PubMed ID: 1072935
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Hyzol and its range of use in the treatment of skin diseases with wet poultice and wet bandages].
    FRIDERICH H
    Medizinische; 1954 Sep; 38():1285. PubMed ID: 13223227
    [No Abstract]   [Full Text] [Related]  

  • 24. [Amino acids in therapy of mental diseases].
    LAVITOLA G; FALCO G
    Osp Psichiatr; 1957; 25(1):43-52. PubMed ID: 13517884
    [No Abstract]   [Full Text] [Related]  

  • 25. [Hepatic encephalopathy and selective amino acid solutions].
    De Martiis M; D'Ottavi R; Fontana M; Patrizi P
    Clin Ter; 1983 Jan; 104(1):53-8. PubMed ID: 6337772
    [No Abstract]   [Full Text] [Related]  

  • 26. [The role of nonessential amino acid in postoperative "protein sparing" treatment].
    Jiang ZM
    Zhonghua Wai Ke Za Zhi; 1983 Jan; 21(1):10-2, 61. PubMed ID: 6406181
    [No Abstract]   [Full Text] [Related]  

  • 27. [A new substance for the therapeutic embolisation of renal tumours (author's transl)].
    Bücheler E; Hupe W; Klosterhalfen H; Altenähr E; Erbe W
    Rofo; 1978 May; 128(5):599-603. PubMed ID: 149073
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Loss of amino acid during hemodialysis and essential amino acid supplementation in patients on regular dialysis treatment (author's transl)].
    Iida N; Shirai D; Iwasaki E; Okada H; Uchisaka T; Hamano M; Mikami H
    Nihon Jinzo Gakkai Shi; 1977 Nov; 19(11):909-19. PubMed ID: 609147
    [No Abstract]   [Full Text] [Related]  

  • 29. [Treatment of various liver diseases with a liver-drug combination composed of essential amino acids, vitamin B, folic acid and nicotinamide].
    Gniwotta E; Kirchdorfer AM
    Z Allgemeinmed; 1973 Jun; 49(16):799-804. PubMed ID: 4268237
    [No Abstract]   [Full Text] [Related]  

  • 30. [Therapy of hepatic encephalopathy. Modification of the plasma aminogram using amino acid infusions].
    Ferenci P; Funovics J; Wewalka F
    Chir Forum Exp Klin Forsch; 1978; (1978):183-9. PubMed ID: 110563
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Observations on the integration with essential amino acids of a low-protein diet in the treatment of grave renal insufficiency].
    Arduini M; Alpi-Quirighetti G; Bonomolo A; Prosperi F; Rossini P
    Minerva Urol; 1966; 18(2):65-7. PubMed ID: 5917055
    [No Abstract]   [Full Text] [Related]  

  • 32. [New therapeutic trends in osteoarticular diseases and collagen diseases based on the biochemistry of those tissues].
    Morejón Sobrón E
    Folia Clin Int (Barc); 1966 Apr; 16(4):208-15. PubMed ID: 5943591
    [No Abstract]   [Full Text] [Related]  

  • 33. [Further data on the use of a combination of amino acids and cobamamide. Its therapeutic use in childhood].
    Tondo U; Murialdo P
    Minerva Pediatr; 1974 Jun; 26(20):1049-51. PubMed ID: 4845097
    [No Abstract]   [Full Text] [Related]  

  • 34. [Nutrition problems in kidney diseases].
    Kult J
    Infusionsther Klin Ernahr; 1976 Apr; 3(2):72-7. PubMed ID: 965082
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Behavior and therapeutic use of amino acids in pulmonary tuberculosis].
    FAVEZ G
    Exp Med Surg; 1954; 12(2):273-8. PubMed ID: 13161944
    [No Abstract]   [Full Text] [Related]  

  • 36. [Course of liver disease under W2-pan-aminon treatment, electrophoretically demonstrated].
    WOLF G
    Med Monatsschr; 1955 May; 9(5):314-8. PubMed ID: 13244221
    [No Abstract]   [Full Text] [Related]  

  • 37. [Considerations on an amino acid and arsenical preparation (trophistine) in tuberculosis].
    ETTORE F
    Rass Giuliana Med; 1952 Feb; 8(2):55-60. PubMed ID: 14949445
    [No Abstract]   [Full Text] [Related]  

  • 38. Amino acid metabolism in patients with advanced uremia and in patients undergoing chronic dialysis.
    Kopple JD; Jones MR
    Adv Nephrol Necker Hosp; 1979; 8():233-68. PubMed ID: 115243
    [No Abstract]   [Full Text] [Related]  

  • 39. Immuno-, phagocytosis-modulating, and antitoxic properties of amino acids and peptide preparations.
    Belokrylov GA; Derevnina OY; Molchanova IV; Sorochinskaya EI
    Drug Dev Ind Pharm; 1998 Feb; 24(2):115-27. PubMed ID: 15605441
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Influence of amino acid therapy in chronic idiopathic pruritus ani.
    LEVINE AJ; DAVIS OF; HORWITZ B; SLOAN N; BECK C
    Gastroenterology; 1958 Oct; 35(4):409-13. PubMed ID: 13586548
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.